Health

  • October 20, 2026

    Freshfields Hires Gibson Dunn Life Sciences Lawyer In DC

    Freshfields LLP has hired a former Gibson Dunn & Crutcher LLP lawyer who focuses his practice on identifying, assessing and mitigating risks associated with U.S. Food and Drug Administration oversight, the firm recently announced.

  • October 19, 2026

    95K Contact Lens Buyers Nab Cert. In Hubble Substitution Suit

    A California federal judge has certified a class of roughly 95,500 California contact lens purchasers who subscribed to Hubble Contacts, an online service accused of deceiving its customers by secretly substituting every customer order with its own Hubble-brand lenses.

  • October 19, 2026

    FCC Report Says Tribes Lack Funding For Suicide Hotline

    A dozen states reported collecting a total of $240.5 million in fees during the 2025 calendar year to support a federal suicide hotline while seven tribal authorities said they lack a funding mechanism to do so, according to a Federal Communications Commission report.

  • October 19, 2026

    23andMe Successor Co. Inks $6M Data Breach Deal With Calif.

    California and 23andMe's corporate successor have reached a $6 million settlement that, if approved, would resolve the state's allegations that the genetic testing company failed to protect customers' sensitive information in a 2023 data breach, as well as the state's objection to 23andMe's sale of genetic data during bankruptcy proceedings.

  • October 19, 2026

    5 Firms Build Migraine-Focused TriGemX's $600M SPAC Deal

    Biotechnology company TriGemX Bio on Monday unveiled plans to go public by merging with special purpose acquisition company TCGX Acquisition Corp. in a deal built by five law firms that creates a combined company with a $600 million post-transaction equity value.

  • October 19, 2026

    Port Of Seattle Challenges Trump Grant Terms Targeting DEI

    The Port of Seattle and several Washington cities and counties asked a federal judge to block the Trump administration from enforcing new grant conditions that would threaten $87 million in funding, arguing the restrictions lack clear standards of conduct.

  • October 19, 2026

    Pot Co. Ascend Says It Had Good Reasons To Fire Executive

    Major cannabis company Ascend Wellness has urged a New York federal judge to find that a wrongful termination case brought by a former executive should be thrown out because the company documented a record of inappropriate behavior and fulfilled its duties to communicate its reasons for firing him.

  • October 19, 2026

    Accused In $91M Health Plan Scam Asks To Halt FTC Suit

    A woman accused of running a $91 million fraudulent health benefits scheme with her brother urged a Florida federal court on Monday to pause the Federal Trade Commission's lawsuit against her if related criminal charges proceed in court. 

  • October 19, 2026

    Mass. Court Affirms Doctor's Partial Win Over Insurer

    A doctor whose career was cut short after losing the use of his feet is entitled to damages from Paul Revere Life Insurance Co. for breach of contract and unfair settlement practices under state law, but cannot revive other claims tossed by a judge or extend the statute of limitations, an intermediate appellate court said Monday.

  • October 19, 2026

    Prior 5th Amendment Pleadings Complicate Mylan Testimony

    Mylan can use deposition testimony from one current and one former executive in next year's price-fixing trial, a Connecticut federal judge ruled Friday, but state attorneys general can bring up the company "pulling the strings" in the witnesses' decision to testify after originally invoking the Fifth Amendment.

  • October 19, 2026

    Biz Groups Back Health System's Win In 401(k) Forfeiture Suit

    The U.S. Chamber of Commerce and an employee benefit administrator trade group backed a Louisiana healthcare system's win over a lawsuit challenging its use of forfeited 401(k) funds to cover employer contributions, telling the Fifth Circuit that federal regulations have greenlighted the practice for decades.

  • October 19, 2026

    DOJ Appeals New Trial Order In Ex-NFL Player's Fraud Case

    The U.S. Department of Justice said it's asking the Fifth Circuit to review a Texas federal judge's decision to grant a new trial for a former NFL player convicted in a $328 million Medicare billing scheme.

  • October 16, 2026

    Conduent Inks $80M Breach Deal With 62M Class Members

    Victims of a data breach at Conduent Business Services LLC on Friday asked a New Jersey federal judge to greenlight an $80 million settlement resolving their claims that the company failed to adequately protect sensitive personal and health information of about 62 million people.

  • October 16, 2026

    2nd Circ. Denies Rehearing In Tylenol Autism Suits

    The Second Circuit on Friday denied a bid by Tylenol maker Kenvue and several retailers to reconsider its ruling that a district court improperly excluded expert testimony for plaintiffs who claim prenatal exposure to the over-the-counter pain reliever causes autism and ADHD.

  • October 16, 2026

    NY, Conn. Secure $2.7M Deal Over Health Network Data Breach

    A pediatric health network and its information technology manager have agreed to pay $2.7 million to resolve the New York and Connecticut attorneys general's claims that they failed to institute "common" security measures to protect the personal data of patients impacted by a 2024 data breach, the states announced Friday. 

  • October 16, 2026

    Suing The Trump Admin Can Have Massive Impact, Attys Say

    Lawyers representing clients against the federal government spoke Friday about the challenges and rewards of such litigation in the Trump era, with plaintiff-side powerhouse Elizabeth Cabraser pointing to the potential for massive impact, including one case in which she successfully got more than a billion dollars in grant funding reinstated.

  • October 16, 2026

    NY Nursing Home Hit With $6.8M Verdict In Understaffing Case

    A New York state jury reached a $6.8 million verdict against a nursing home accused of understaffing its approximately 62-bed facility and causing severe patient neglect, counsel for a certified class of residents at the facility announced Friday.

  • October 16, 2026

    Hospital Operator Challenges NC AG's Power Over Merger

    HCA Healthcare is taking another crack at throwing out the North Carolina attorney general's suit alleging HCA broke its promise to maintain a certain level of care at an Asheville hospital it purchased, saying his office lacks the power to enforce a merger between two private parties.

  • October 16, 2026

    Device Co. Accused Of Shorting Co-Founder's Payments

    The co-founder of a company that sells medical devices told a Colorado state court Thursday that the company lowered the percentage he is owed of $7.7 million in outstanding receivables from a client without approval.

  • October 16, 2026

    FTC Wants More Info On $350M Surgical Supplies Deal

    The Federal Trade Commission has requested additional information about MiMedx Group Inc.'s planned $350 million purchase of Sanara MedTech Inc., a company that develops and commercializes products for use during surgery.

  • October 16, 2026

    City Therapeutics' Upsized $200M IPO Joins Biotech Wave

    Blood clot-focused biotechnology firm City Therapeutics began trading publicly Friday after raising $200 million in its upsized initial public offering steered by Goodwin Procter LLP and Cooley LLP, joining a wave of biotechnology public listings over the past few weeks.

  • October 16, 2026

    Could A Criminal Sentencing Case Upend Loper Bright?

    U.S. Supreme Court Justice Neil Gorsuch is concerned that a ruling instructing trial courts to defer to the U.S. Sentencing Commission's interpretation of federal sentencing guidelines could blow a "pretty big hole" in the court's recent rejection of deference doctrines. His colleagues, however, don't appear as perturbed.

  • October 16, 2026

    States Win 1st OK Of $400M Sandoz Generic Price-Fixing Deal

    A Connecticut federal judge granted preliminary approval Friday to a $400 million settlement between a coalition of states, Sandoz Inc. and its subsidiary Fougera Pharmaceuticals Inc. over allegations of generic drug price-fixing and market allocation, setting aside $280 million as restitution.

  • October 16, 2026

    Aetna Drops Medical Billing Suit Against Acupuncture Clinic

    Aetna, a Washington acupuncture clinic and a retired doctor have agreed to end the insurer's suit claiming it paid more than $800,000 because of fraudulent billing for medical services, according to a federal court filing.

  • October 16, 2026

    Conn. Doctor Settles Fraud Claims Over COVID Test Billing

    A Connecticut doctor who has pursued numerous lawsuits against insurers for COVID-19 testing reimbursements, with a mixed record of success, has agreed to pay more than $850,000 to settle allegations that his companies submitted inflated bills to government programs, authorities said Friday.

Expert Analysis

  • Rare DOJ Military Bias Suit Shows Peril Of Co. Admissions

    Author Photo

    Although the government rarely litigates Uniformed Services Employment and Reemployment Rights Act claims against private employers, Opara v. UV Memory Care demonstrates that it will do so when an employer's own admissions build the case, potentially resulting in significant compliance obligations and long-term consequences, says Bradford Kelley at Littler.

  • Series

    Judges On AI: Examining Administrative, Organizational Uses

    Author Photo

    U.S. District Judge Alan Albright of the Western District of Texas examines how artificial intelligence could transform a court's ability to deal with administrative work and organize materials when preparing for hearings or drafting opinions, thereby affording judges more time to resolve contested issues.

  • USPTO-Fed. Circ. Split Complicates Machine Learning Patents

    Author Photo

    The wide chasm between the USPTO's and the Federal Circuit's approach to eligibility for machine learning patents means that patent drafters must avoid functional claiming and specifications if they hope to avoid invalidation of a machine learning patent at the appellate court, says attorney Michael Kiklis.

  • Class Actions At The Circuit Courts: July Lessons

    Author Photo

    In this month's review of class action appeals, Mitchell Engel at Shook Hardy discusses four recent rulings involving wage and hour allegations, medical care for incarcerated individuals, oil and gas royalty payments, and nuisance claims.

  • AG Watch: Ohio AG Joins State Antitrust Enforcement Trend

    Author Photo

    Amid the recent reprioritization in the federal government's competition enforcement agenda, two recent cases provide critical insight into how the Ohio attorney general will proceed in the relatively unprecedented trend of state attorneys general aggressively pursuing antitrust matters, say attorneys at BakerHostetler.

  • Series

    Being A Singer Makes Me A Better Lawyer

    Author Photo

    Before law school, I spent seven years trying to make it as a professional singer in Los Angeles, and nearly everything I learned about preparation, humility, confidence and more has followed me into my legal practice, says Jessica Caterina at Moses & Singer.

  • Mass. UHC Fraud Suit Signals States' Medicaid FCA Push

    Author Photo

    Massachusetts' recently filed False Claims Act suit alleging UnitedHealthcare misrepresented the health status of enrollees in a Medicaid senior care organization plan it managed pushes forward a new phase of state-level scrutiny of managed care data and Medicaid payment mechanisms, say Li Yu at Bernstein Litowitz, Ellen London at London & Naor and Gwendolyn Stamper at Vogel Slade.

  • The Growing Antitrust Risks Of AI Pricing For Health Insurers

    Author Photo

    Attorneys at Patterson Belknap provide an overview of the increased risk of antitrust enforcement for health insurance companies using algorithmic price models, including in the form of multidistrict private litigation, new state and federal bills, and potential federal enforcement.

  • FDA Draft Guidance Maps Payor Strategy For Psychedelics

    Author Photo

    Recently revised guidance from the U.S. Food and Drug Administration will operationalize a framework permitting drug developers to share product information with insurance companies, giving psychedelic therapeutics developers a road map for building a successful payor infrastructure before approval, says Kimberly Chew at Husch Blackwell.

  • Trade Secret Practice Tips From The 1st Half Of 2026

    Author Photo

    Intellectual property attorneys should consider what several significant developments in 2026 thus far mean for how they protect, litigate and value trade secrets, focusing on new state noncompete bans, cases scrutinizing how plaintiffs identify trade secrets and federal rulings on damages doctrines, say attorneys at Faegre Drinker.

  • Preparing For Next Congress With Eye On Investigation Risk

    Author Photo

    Rod Rosenstein, Brian Whisler and Bruce Linskens at Baker McKenzie offer advice for organizations seeking to build a proactive response plan to potential congressional oversight as the election looms.

  • Opinion

    Denying Emergency Abortion Care Is A Liability Oversight

    Author Photo

    Health systems in states with abortion bans should consider that refusing to provide emergency abortion care carries greater legal risk than the risk of prosecution under post-Dobbs laws for providing treatment, say Kimberly Chernoby at FemInEM and Rachel Rebouché at the University of Texas, Austin School of Law.

  • Carbon Health Settlement Highlights Why Evidence Is Key

    Author Photo

    The California Attorney General's Office's first-of-its-kind settlement with Carbon Health, imposing penalties for alleged corporate practice of medicine violations, shows that friendly professional corporation challenges usually hinge not on the parties' management services agreement, but on whether the operational record matches it, says Ben Dubin at VC Expert Services.

  • How To Brace For A Potential Democratic Oversight Push

    Author Photo

    With the possibility of a shift in congressional control after the November midterm elections, companies and their general counsel should prepare now by mapping oversight exposure, reviewing government interactions, preserving records and developing coordinated communications strategies, say attorneys at Hogan Lovells.

  • Remote Work Rulings Show ADA Fights Hinge On Process

    Author Photo

    Two opposite outcomes in recent Fifth Circuit and D.C. federal court cases underscore that the legality of denying employees' disability accommodation requests for remote work depends less on broad policy and more on how it's applied, says Paul Sweeney at Ice Miller.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.